Skip to main content

Table 1 Rare CNVs discovered in the paediatric obsessive compulsive disorder (EO-OCD) patients including inheritance pattern

From: High resolution chromosomal microarray analysis in paediatric obsessive-compulsive disorder

Code

Gender

Diagnosis

Comorbid tics

CNV size (kb)

chromosomal location (hg19)

Genes within CNV

Inheritance

Comments

a) Deletions carriers

9025014001

female

OCD

yes

51

2p16.3:51234059–51285498

NRXN1

de-novo

–

9925026001

male

OCD

no

170

3p22.1:42928225–43098107

ZNF662, KRBOX1, FAM198A

Maternal

Absent in healthy brother

9025082001

female

OCD

no

113

4p12:46952619–47065270

GABRA4, GABRB1

Maternal

–

9025015001

male

OCD

no

210

4q28.3:139075297–139285096

SLC7A11 , LINC00499

Maternal

–

9025019001

male

OCD

no

134

6p25.1:6645654–6779499

LY86

n.a.

–

9025107001

female

OCD

no

125

6q22.31:125494942–125619539

TPD52L1, HDDC2

Maternal

–

9025079001

male

OCD

yes

731

7q21.11:83743960–84475183

SEMA3A

Paternal

–

9025101001

male

OCD

no

83

10p11.21:34672540–34755348

PARD3

Paternal

–

9025043001

male

OCD

yes

310

12q23.1:100148198–100458394

ANKS1B , UHRF1BP1L

de-novo

overlap to 190 kb deletion Chr12 (ANKS1B) in European paediatric OCD female [26]

9025045001

female

OCD

no

297

15q21.3:53716860–54014105

WDR72

Maternal

–

9025069001

female

OCD

no

105

15q24.2:76235495–76340932

NRG4

Maternal

–

9025100001

male

OCD

no

1500

16p13.11:15509406–16516109

C16orf45, KIAA0430, NDE1, MIR484, MYH11 , FOPNL, ABCC1 , ABCC6, NOMO3, MIR3179–1, MIR3179–3, MIR3179–2, MIR3180–1, MIR3180–3, MIR3180–2, PKD1P1

n.a.

overlap to 783 kb duplication Chr16 (MYH11,KIAA0430,MPV17L,NDE1,FOPNL,C16orf45,NPIPA5,ABCC1) in European paediatric OCD male maternally inherited [26]

9025040001

female

OCD

no

100

16p13.3:6294808–6394343

RBFOX1

Maternal

–

9025076001

female

OCD

no

373

19q13.12:37378717–37752059

ZNF829, ZNF568, ZNF420, ZNF585A, ZNF585B, ZNF383

Maternal

–

9925012001

male

OCD

yes

54

21q21.1:22856032-22910383

NCAM2

n.a.

–

9925015001

male

OCD

no

279

Xq11.2:63540728–63819338

MTMR8

Maternal

Brother (Anxiety) carrier of CNV as well; Mother (Anxiety)

9025093001

male

OCD

no

101

Xq27.3:142869149-142970485

UBE2NL

Maternal

–

b) Duplication carriers

9025030001

male

OCD

no

166

1p21.2:101039885–101205680

VCAM1

n.a.

–

9025106001

female

OCD

no

487

1p31.1:74037092–74524344

LRRIQ3

n.a.

–

9025016001

male

OCD

no

147

1p36.12:22984535–23131772

C1QB, EPHB2

Maternal

–

9025094004

male

OCD

yes

437

1q21.1:145372549–145809279

NBPF10, HFE2 , TXNIP, POLR3GL, ANKRD34A, LIX1L, RBM8A, GNRHR2, PEX11B, ITGA10, ANKRD35, PIAS3 , NUDT17, POLR3C, RNF115, CD160, PDZK1, GPR89A, GPR89C

Maternal

Sister (sub-threshold OCD) carrier of CNV as well; Mother (sub-threshold OCD); overlap to;

(1) 1799 kb duplication Chr1 (ACP6,PRKAB2,CHD1L,LOC100288142,FMO5,GJA8,NBPF24,NBPF8,BCL9,NBPF12,NBPF11,NBPF10,GPR89B,GPR89C,GJA5) in European paediatric OCD male maternally inherited.

(2) 170 kb duplication Chr1 (CD160,RNF115,POLR3C,GPR89A,PDZK1) in European paediatric OCD female, and (3) 165 kb duplication Chr1 (CD160,RNF115,GPR89A,PDZK1) in European paediatric OCD female, [26]

9925022001

female

OCD

no

1380

3p14.2: 60835192–62214802

FHIT , PTPRG

n.a.

–

9025027001

male

OCD

no

278

3p25.2:12374585-12652539

PPARG, TSEN2, LOC100129480, MKRN2, RAF1

Paternal

–

9025029001

female

OCD

no

58

4q13.3:72291016–72349103

SLC4A4

n.a.

–

9025013001

female

OCD

no

67

4q35.1:186023710–186090501

SLC25A4, KIAA1430

n.a.

–

9025091001

male

OCD

no

484

6p21.31:34446474–34930648

PACSIN1 , SPDEF, C6orf106, SNRPC, UHRF1BP1, TAF11, ANKS1A

Paternal

–

9925001001

male

OCD

no

300, 162 & 79

6q14.1:76417785–76718017 76774410–76935941(two) & 17p13.2: 4309542–4388334

SENP6, MYO6 , IMPG1, SPNS3

Paternal

Father CNV on Chr6q14:1; overlap to 73 kb duplication Chr17 (SPNS3) in non-European paediatric OCD male [26]

9025089001

male

OCD

no

246

7q11.23:72576872–72822709

LOC100093631, GTF2IP1, NCF1B, GTF2IRD2P1, NSUN5, TRIM50, FKBP6

Paternal

–

9925007001

female

OCD

yes

258

7q31.33:125882371–126140769

GRM8

Paternal

Absent in sister (OCD)

9025036001

female

OCD

no

89

7q36.1:149318934–149408392

ZNF767

n.a.

–

9025049001

male

OCD

no

153

7q36.3:157134943–157287531

DNAJB6, LGMD1E

Paternal

–

9025077001

male

OCD

yes

158

9p13.3:33989242–34146776

UBAP2, DCAF12

Maternal

–

9025020001

female

OCD

no

52

9q34.13:134065786–134117305

NUP214

n.a.

–

9025067001

female

OCD

no

134

10p15.3:143252–277232

ZMYND11

n.a.

–

9925035001

male

OCD

no

131

11q12.1:58547531–58678042

GLYATL2

n.a.

–

9025073001

female

OCD

no

82

13q14.11:40310481–40392725

COG6

Paternal

–

9925030001

male

OCD

yes

109

13q34:110917586–111026140

COL4A1, COL4A2

Maternal

Absent in healthy sister

9925021001

female

OCD

no

176

14q21.1:42004775–42180366

LRFN5

Maternal

–

9025112001

male

OCD

no

100

14q23.1:58476607–58576320

C14orf37

n.a.

–

9025082001

female

OCD

no

66

18p11.32:2825037–2890695

EMILIN2

not maternal

Mother has only the deletion CNV; father not available

9025043001

male

OCD

yes

80

19p13.11:19749997–19830351

GMIP, ATP13A1, ZNF101, ZNF14

de-novo

–

9925027001

male

OCD

yes

50

19q13.2:39113548–39163701

EIF3K, ACTN4

Maternal

–

9025040001

female

OCD

no

73

20q12:37604490–37677926

DHX35

not maternal

Mother has only the deletion CNV; father not available

9025078001

female

OCD

no

313

Xp11.3:44750716–45063967

KDM6A, CXorf36

Paternal

–

  1. Abbreviation: n.a. not available, −-, not applicable, Underlines, proband carrying both deletions and duplications; Bold, brain/synapse related genes according to gene ontology, PubMed & GEO; Cursive, patients’ codes that were analysed in the previous publication for CNVs larger than 500 kb [24]; Patient # 90–25–079-001, with deletion on 7q21.11:83,743,960–84,475,183(hg19) of 731 kb /previously reported as 7q21.11:83,580,426–84,291,036(hg18) 711 kb [24]. For further details, as well as for control sample findings (e.g. CYBOCA, comorbidities etc.), see Additional file 2: Table S2a & b